MCGUINNESS v. SILGAN CONTAINERS MANUFACTURING CORPORATION

CourtDistrict Court, D. New Jersey
DecidedOctober 13, 2020
Docket2:18-cv-12861
StatusUnknown

This text of MCGUINNESS v. SILGAN CONTAINERS MANUFACTURING CORPORATION (MCGUINNESS v. SILGAN CONTAINERS MANUFACTURING CORPORATION) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MCGUINNESS v. SILGAN CONTAINERS MANUFACTURING CORPORATION, (D.N.J. 2020).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

: KEVIN McGUINNESS, : Civil Action No. 18-12861 (SRC) : Plaintiff, : OPINION : v. : : SILGAN CONTAINERS, et al., : : Defendants. : :

CHESLER, District Judge

This matter comes before the Court on the motion for summary judgment filed by Defendant Silgan Containers Manufacturing Corporation (“Defendant” or “Silgan”), pursuant to Federal Rule of Civil Procedure 56.1 Plaintiff Kevin McGuinness (“Plaintiff” or “McGuinness”) opposes the motion. The Court has reviewed the papers submitted and proceeds to rule without oral argument, pursuant to Federal Rule of Civil Procedure 78. For the reasons that follow, Defendant’s motion for summary judgment will be denied.

I. BACKGROUND This is an employment discrimination action. Plaintiff McGuinness had been employed as a production supervisor for Defendant Silgan. Silgan develops and manufactures metallic

1 As Silgan notes in its brief, it is the sole Defendant in this case. The action was originally filed against various parties identified as “Silgan Containers, Silgan Containers Corporation, Silgan Containers LLC, and Silgan Holdings Inc.” Thereafter, by stipulation, all of these entities were dismissed from the case. See December 11, 2018 Order. containers for food products. In connection with this business, Silgan maintains a 100,000 square foot production facility in Edison, New Jersey (the “Edison facility”). McGuinness was terminated from employment on February 6, 2018. He claims that the termination was motivated by Silgan’s discrimination against him on the basis of his disability

and also in retaliation for his disability-related leaves of absence. Silgan, however, maintains that it terminated McGuinness due to his unsatisfactory job performance, specifically, his failure to address subordinate employees’ misuse of break time. The following synopsis sets forth facts relevant to this motion. A. Plaintiff’s Role at the Edison Facility McGuinness began working at Silgan in October 2014. He was hired as a management trainee. In or about January 2016, McGuinness was promoted to the position of production supervisor. Plaintiff worked at the Edison facility during his entire tenure. Silgan’s Edison facility operates as follows: The production schedule is divided into two twelve-hour shifts, running from 6 a.m. to 6 p.m. and 6 p.m. to 6 a.m. Silgan operates with four

different crews, of approximately 20 to 25 employees per crew. The A and B crews work the day shift, and the C and D crews work the night shift. The crews alternate their respective shifts, working a schedule of four days on and four days off. Each crew has two supervisors. At the time relevant to this suit, McGuinness was assigned to supervise the night shift’s D crew, together with Rob Paprota, a more experienced supervisor. The other night shift crew, that is, the C crew, was supervised by Edward Mulligan and Joseph Balleau. Production supervisors reported to Chip Miklavcic, superintendent of the Edison facility, who in turn reported to Edison facility manager Bryce Bedford. As a production supervisor, McGuinness was a salaried employee. According to the job description proffered in the record, a production supervisor is expected to “lead and direct hourly employees with day instructions to meet production goals and line efficiencies.” (Anders Decl., Ex. K.) The description identifies five essential job functions of a Silgan production supervisor:

(1) maintain active involvement in employee safety and ensure an overall safe workplace; (2) adhere to quality standards; (3) lead the manufacturing unit in standard operating procedures; (4) employ effective communication skills to direct work assignments in compliance with the collective bargaining agreement; and (5) operate in a manner conducive to achieving continuous improvement using the principles of lean manufacturing. McGuinness received a mixed review after his first year as a production supervisor. As to the essential functions, his January 2017 review noted that he met all the requirements for safety and quality and most of the requirements for continuous improvement. He did not, however, meet the leadership objective. The review noted that “Kevin needs to improve his ability to understand issues throughout the shift and make decisions to improve these issues . . .

Throughout this year, Kevin has been given feedback and has made improvements and will look for this to continue.” (Anders Decl., Ex. P at D-0051.) The overall assessment noted that he was in the category of “progressing” (with the other two categories being “significant deficiencies” and “promotable”). Id. B. Plaintiff’s Medical Leave of Absence In July 2017, McGuinness, then 45 years old, became seriously ill with kidney disease. Both of his kidneys were blocked, and he had to be hospitalized. Effective July 25, 2017, Silgan placed McGuinness on short-term disability and approved his leave of absence under the Family and Medical Leave Act (“FMLA”). McGuinness remained on continuous leave from July until November 6, 2017. During this period of leave, McGuinness’ health condition worsened. In early September, he was admitted to JFK Medical Center and diagnosed with complete kidney failure. Following

surgery and dialysis, his condition improved to Stage 4 kidney failure. Shortly thereafter, McGuinness was discharged from hospital care but advised that he would require dialysis and eventually a kidney transplant. He continued to recuperate at home. McGuinness was cleared by his doctor to return to work as of November 6, 2017 but with restrictions. The doctor noted that it was “medically advised” that McGuinness be scheduled for “maximum 4 day work week x 3 months to continue management of medical conditions.” (Schalk Decl., Ex. B at D-0247.) Nevertheless, when McGuinness returned to work at Silgan, the company’s doctor cleared him to return to work on full duty, with no conditions or restrictions. In his declaration submitted in opposition to the motion for summary judgment, McGuinness asserts that Silgan scheduled him for six-day work weeks, exceeding the limitations advised by

McGuinness’s physician and exceeding the four-day work weeks he had been assigned prior to his medical leave. On November 8, 2017, during his third shift upon returning to work, McGuinness began to experience extreme pain and blood in his urine. He left work and immediately sought treatment at JFK Medical Center. This incident required McGuinness to request a second leave of absence from work under the FMLA, which Silgan granted. McGuinness underwent same-day surgical procedures under general anesthesia on November 10 and November 17. He was cleared by his urologist to return to work on November 22, 2017, again with restrictions. The urologist stated that McGuinness should be placed on “light duty and not be able to lift anything over five pounds” for the remainder of the week. (Schalk Decl., Ex. G at D-0148). Again, upon McGuinness’s return to work, Silgan’s company doctor placed no limitations or conditions on the tasks McGuinness should be expected to perform. McGuinness testified at his deposition that at some point thereafter, he began to inquire with Silgan’s human resources department about the

possibility of taking long-term disability. The next event of any consequence in McGuinness’s employment occurred approximately seven weeks later, on January 12, 2018. On that date, he was called in for a meeting with management and human resources staff to discuss a problem involving break time violations at the Edison facility. The details of this meeting will be set forth in more detail below. C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Adickes v. S. H. Kress & Co.
398 U.S. 144 (Supreme Court, 1970)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
St. Mary's Honor Center v. Hicks
509 U.S. 502 (Supreme Court, 1993)
Kathleen M. Victorelli v. Shadyside Hospital
128 F.3d 184 (Third Circuit, 1997)
Cristen M. Gleason v. Norwest Mortgage, Inc
243 F.3d 130 (Third Circuit, 2001)
Erdman v. Nationwide Insurance
582 F.3d 500 (Third Circuit, 2009)
Muller v. Exxon Research & Engineering Co.
786 A.2d 143 (New Jersey Superior Court App Division, 2001)
Viscik v. Fowler Equipment Co., Inc.
800 A.2d 826 (Supreme Court of New Jersey, 2002)
Zive v. Stanley Roberts, Inc.
867 A.2d 1133 (Supreme Court of New Jersey, 2005)
Clowes v. Terminix International, Inc.
538 A.2d 794 (Supreme Court of New Jersey, 1988)
Andersen v. Exxon Co.
446 A.2d 486 (Supreme Court of New Jersey, 1982)
Parker v. Hahnemann University Hospital
234 F. Supp. 2d 478 (D. New Jersey, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
MCGUINNESS v. SILGAN CONTAINERS MANUFACTURING CORPORATION, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcguinness-v-silgan-containers-manufacturing-corporation-njd-2020.